Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.

MLA

Goux, Marine, et al. “Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.” Bioconjugate Chemistry, vol. 28, no. 9, Sept. 2017, pp. 2361–71. EBSCOhost, https://doi.org/10.1021/acs.bioconjchem.7b00374.

APA

Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28(9), 2361–2371. https://doi.org/10.1021/acs.bioconjchem.7b00374

Chicago

Goux, Marine, Guillaume Becker, Harmony Gorré, Sylvestre Dammicco, Ariane Desselle, Dominique Egrise, Natacha Leroi, et al. 2017. “Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.” Bioconjugate Chemistry 28 (9): 2361–71. doi:10.1021/acs.bioconjchem.7b00374.